18.10.2018
- Novartis has agreed to buy US biopharma Endocyte, gaining access to radiopharmaceuticals, which the Swiss drugmaker has identified as a key growth driver of its business. Under the...
27.09.2018
- Drugmaker Novartis has announced plans to cut around 2,200 jobs in Switzerland and exit its site in Grimsby, UK, as it transforms its global manufacturing network and product...
19.09.2018
- The pharmaceutical industry has gone through two decades of rapid technological innovations. These include combinatorial chemistry, recombinant DNA technology, development of...
10.09.2018
- Novartis has agreed to sell parts of its Sandoz US portfolio to Aurobindo Pharma USA as the Swiss drugmaker drives ahead with its strategy to focus on higher value medicines...
06.08.2018
- The European Medicines Agency (EMA) is scaling back and suspending some activities as it loses more staff than initially anticipated in advance of its relocation from the UK to the...
05.07.2018
- The US Food and Drug Administration‘s (FDA) recent approval of a new migraine treatment marketed by Amgen and Novartis has met with an enthusiastic response since it was...
02.07.2018
- In a move that had been widely expected, Swiss drugs giant Novartis has announced that it will spin off its Alcon eye care division into a separate standalone company. The...
24.05.2018
- An ill-advised “advisory” deal with the personal attorney of US president Donald Trump continues to plague Swiss drugmaker Novartis. Two weeks ago the company made headlines when...
